UNC Health Medication Formulary
Change Request Form Chemical/SDS Search UNC Health.org
QR Code Add Formweb to your mobile device
Android iOS
Click here to submit safety event reports via SAFE
UNC Health Medication Formulary
Change Request Form Chemical/SDS Search UNC Health.org
Search results for:

denosumab

denosumab
Drug Name Form Strength ARHS Blue Ridge Caldwell Chatham Johnston Lenoir Medical Center Nash Pardee Rex Rockingham Southeastern Wayne Youth Behavioral Health
Denosumab (Jubbonti) SOLUTION, SUBCUTANEOUS 60 mg/mL (1 mL)          
Denosumab (Prolia) SOLUTION, SUBCUTANEOUS 60 mg/mL (1 mL)        
Denosumab (Wyost) SOLUTION, SUBCUTANEOUS 70 mg/mL (120 mg/1.7 mL)              
Denosumab (Xgeva) SOLUTION, SUBCUTANEOUS 70 mg/mL (120 mg/1.7 mL)          

UNC Health

System Formulary Restriction:

Denosumab (Prolia): restricted to patients in outpatient or clinic encounters (ie, no inpatient use) who meet the following 
criteria:

    • Continuation of therapy in patients who previously received Prolia
    • Initiation of therapy in patients with insurance restrictions that require Prolia, or do not cover Jubbonti 

Denosumab (Xgeva): restricted to patients in outpatient or clinic encounters (ie, no inpatient use) who meet the following 
criteria:

    • Continuation of therapy in patients who previously received Xgeva
    • Initiation of therapy in patients with insurance restrictions that require Xgeva, or do not cover Wyost

Treatment of Hypercalcemia of Malignancy in Adults Guideline

Med Center

UNC Medical Center Formulary Restrictions

Last updated: Dec. 16, 2025






This site is intended for the staff of UNC Health.
While others may view accessible pages, UNC Health makes no warranty, express or implied,
as to the use of this information outside of UNC Health.

Copyright © 2026 Rpharmy, LLC ­ All Rights Reserved